Stroke and Systemic Embolism Risk Is Highest with HFpEF Among Heart Failure Types
Study authors assessed the risk of stroke and systemic embolism in patients with atrial fibrillation and heart failure according to HF types.
Atrial Fibrillation
SGLT2 Inhibitor Use Linked to Reduced Atrial Arrhythmia Risk in T2DM
This meta-analysis aimed to determine the association between SGLT2i use and arrhythmias in patients with T2DM or HF.
Renal Dysfunction, Lower Body Weight May Increase DOAC-Associated Bleeding Risk in AF
The authors reported that 25 of the total 233 patients included in the study experienced a bleeding event.
Marine Omega-3 Fatty Acid, Vitamin D Do Not Cut Risk for A-Fib
Neither marine omega-3 fatty acids, EPA and DHA, nor vitamin D3 are associated with a reduction in the risk for incident atrial fibrillation.
Deep Neural Networks Using 12-Lead ECG Predicts New-Onset AF
Deep neural networks using information from a12-lead ECG can predict new-onset atrial fibrillation (AF) risk in patients with no prior history of AF.
Wearable Continuous ECG Monitor Effectively Detects AF in Older Adults With Hypertension
The study objective was to evaluate whether screening older individuals for AF with a wearable electrocardiographic monitor would be effective, detect a high rate of AF, and prompt anticoagulation in a significant number of patients.
Atrial Fibrillation After TAVR May Be Associated With Changes in LVMI
The presence of AF after TAVR may be associated with changes in left ventricular mass index.
Type 2 Myocardial Infarction Phenotype
Type 2 myocardial infarction (MI) has a unique cardiovascular phenotype, distinct from that of type 1 MI.
Benefits of Statin Use in Patients With AF
Treatment of patients with atrial fibrillation with statins was found to be associated with reduced all-cause and cardiovascular mortality.
Cryoballoon Ablation as Initial Treatment for Paroxysmal AF?
Rates of atrial tachyarrhythmia recurrence were found to be lower in patients receiving catheter cryoballoon ablation vs antiarrhythmic pharmacotherapy as first-line intervention for treatment-naive, symptomatic, paroxysmal atrial fibrillation.
- Loading...
Loading...
Next post in Arrhythmia
Loading... 
Loading...